News - Ambrx

Filter

Current filters:

Ambrx

Popular Filters

Ambrx signs up to $300 million deal with Merck & Co

19-06-2012

Privately-held California-based Ambrx has entered into a collaboration with US drug giant Merck & Co…

AmbrxLicensingMerck & CoPharmaceuticalResearch

Bristol-Myers teams up with Ambrx for novel biologics programs in diabetes and heart failure

23-09-2011

US drug major Bristol-Myers Squibb (NYSE: BMY) revealed yesterday that it has teamed up with privately-held…

AmbrxBristol-Myers SquibbCardio-vascularDiabetesLicensingPharmaceutical

Back to top